Ceragon Extends Credit Facility to 2028, Relaxes Covenants, and Discloses New Litigation
CRNT sits 18% above its 52-week low of $1.85.
Summary
Ceragon extended its credit facility to 2028 with relaxed covenants and disclosed a probable $1.16M class action settlement plus two new lawsuits totaling ~$1.56M.
Key Events · Legal and Risk Events · CRNT
-
Credit Facility Extended to 2028
Term extended by 26 months to August 31, 2028. Bank guarantee lines cut by $20.9M to $20.0M, with a new $20.0M uncommitted line approved.
-
Covenants Relaxed
Net debt-to-receivables and net debt-to-working-capital ratios increased from 30% to 50%, giving the company more financial flexibility but indicating lender concessions.
-
Class Action Settlement Estimate
Probable loss under the pending class action settlement estimated at $1,162 thousand; deadline for finalizing settlement extended to September 1, 2026.
-
New Litigation Disclosed
Ceragon Peru sued for ~$560K by a subcontractor; Ceragon Brazil sued for ~$1M by a customer alleging breach of contract.
Analysis · CRNT · Manufacturing
Ceragon amended its revolving credit facility, extending the term to August 31, 2028, while reducing bank guarantee lines by $20.9 million and adding a $20 million uncommitted line. The amendment also relaxes financial covenants, raising the net debt-to-receivables and net debt-to-working-capital ratios from 30% to 50%. This provides more headroom but signals lenders demanded looser terms. Separately, the company disclosed a probable $1.16 million class action settlement loss and two new lawsuits in Peru and Brazil totaling about $1.56 million. These legal items are modest relative to the company's size but add to an already complex risk profile.
At the time of this filing, CRNT was trading at $2.18 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $200.9M. The 52-week trading range was $1.85 to $3.29. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.